Try our Advanced Search for more refined results
Life Sciences - April, 2010
170 articles
- Mexican Lawmakers Back Tougher Antitrust Fines
- FDA Dropped Ball On Heparin Probe: GOP Lawmakers
- Watson Faces Suits Over Trilipix, Rapamune ANDAs
- Wyeth, Schwarz Escape Reglan Failure-To-Warn Suit
- Law Firms Prepare For Wave Of Health Care Work
- Axiom Off Hook For Infringement Of Electrotherapy IP
- Neurontin Purchasers Ask To Amend Class Definition
- J&J Unit Settles Off-Label Marketing Claims For $81M
- 2nd Circ. Urges En Banc 'Pay-For-Delay' Rehearing
- Grassley Pushes For Post-Market Drug Safety Measures
- Schwarz Pays $22M To Settle Medicare Fraud Cases
- CellCyte CEO Fraud Claims Can Move Forward
- Dentsply Strikes Deal To Avoid Antitrust Trial
- Medtronic To Buy ATS Medical In $370M Deal
- Allstate Challenges Wyeth Win In Ativan Coverage Suit
- King & Spalding Lures Sidley Health Industry Pro
- Sandoz Resolves Takeda Patent Dispute Over Actos
- Fed. Circ. Upholds Invalidity Of J&J Concerta Patent
- 3M Wins Bid To Toss Faulty Respirator Suit
- More Plaintiffs Tossed From ReNu Lens Solution MDL
- Forest, Orchid Resolve Namenda Patent Fight
- Boston Scientific Stent Fraud Class Action Tossed
- Abbott, Lilly, Others Hid Miscarriage Drug's Risks: Suit
- American Eagle Gets Do-Over In $258M Citi ARS Suit
- Eastern District Of Texas Rocket Docket Still Has Fuel
- CIBA Loses Injunction Bid In Acuvue Case
- Vioxx Ruling A Boost For Securities Suits: Attys
- Alcon Settles Synergetics Tying Suit For $32M
- 280K Defibrillators At Risk For Malfunction, FDA Warns
- Biotest Contract Suit Over Nabi-HB Remains In Fla.
- Guidant's $296M Plea Deal In Defibrillator Case Rejected
- Fed. Circ. Nixes $4.4M In Sanctions Against McDermott
- Avigen, MediciNova Settle Shareholder Suit Over Deal
- The EU Probe Into Pharmaceutical Patent Settlements
- Teva Attacks Watson Over Generic Menopause Drug
- Novartis Manager Withheld Info About Employee's Rape
- AstraZeneca Set To Seal $520M Deal In Seroquel Case
- FDA Unveils New Analysis Rules For Medical Devices
- Shire Targets Teva Over Generic Intuniv
- Drugstores Ask Court To Reconsider Plavix Ruling
- Fed. Circ. To Review Inequitable Conduct Standards
- Davis Polk Reps Charles River In $1.6B WuXi Deal
- Suit Accusing Amgen Of Kickbacks Gets The Boot
- Clients Say Fen-Phen Lawyer Overcharged $29M
- Abbott, Hospira Off Hook In ERISA Class Action
- Latham Advises Thoratec In $136M Danaher Deal
- Aetna, Humana Latest To Settle In OxyContin MDL
- Celgene, Novartis Settle With Barr Over Generic Ritalin
- Jury Finds Pfizer's Protonix Patent Valid
- Pay-For-Delay Deals Remain In FTC's Crosshairs
- GCs Detail Do's and Don'ts Of Keeping Business
- Ex-Fish, Ballard Attorneys Open Atlanta IP Boutique
- FDA Takes Action To Reduce Infusion Pump Risks
- Fujitsu Inks Deal In Acacia Unit's Data Storage IP Suit
- Group Asks SEC To Review CVS Stock Sales
- Medtronic Recall Earns FDA's Most Serious Rating
- Focalin IP Deal Between Celgene, Actavis Wins OK
- Watson Appeals Loss In Seasonique Spat With Teva
- E-Discovery Challenges Presented By Voice Mail
- Saccharin May Be Dropped From EPA Hazard List
- Pfizer Responds To FDA Over Geodon Clinical Trial
- St. Jude Settles Doctor's Pacemaker Patent Action
- Netgear Settles In Acacia Unit's Data Storage IP Suit
- Bayer Drops Case Against Lupin Over Generic Cipro
- An Eye On Acquiring Minority Interests
- Senator Wants To Snuff Out Candylike Tobacco
- Congressional Testimony: What To Do (And Not Do)
- Waiver Of Attorney-Client Privilege After Seagate
- Boehringer Pays $7.75M To Settle AWP Allegations
- Salt Report Spurs FDA To Form Attack Plan
- New Damages Trial Granted In Wal-Mart Medicine Suit
- Compellent Dropped From Data Storage Patent Suit
- Howrey IP Litigator Jumps To Akin Gump's DC Office
- 3 Claims Of Schering's Zetia Patent Found Invalid
- Synthon Seeks To Shift Lilly Adcirca Battle To NC
- Steris Offers Device Rebates To Settle FDA Claims
- BarrierMed CEO Settles SEC $11M Fraud Suit
- Howmedica Faulty Hip Implant Suit Preempted: Judge
- No Cert For Fresenius In Baxter Dialysis Patent Case
- Eli Lilly To Buy Back Cymbalta Rights For $400M
- Pfizer, Wyeth Antitrust Complaint Nixed For 3rd Time
- Mars Sues Supplement Makers Over Cocoa Patents
- Miss. High Court Revives State AWP Suit Against Bayer
- Reverse Payments, Mergers Take Center Stage In Q1
- Biovail Files 2nd Suit Over Watson's Aplenzin ANDA
- MDL Panel Won't Centralize Pain Pump Suits
- Wal-Mart, J&J Toxic Baby Products Suit Stays Alive
- 3rd Circ. Upholds Dentsply Wins In Antitrust Cases
- Secondary Payor Liability In Settling Medicare Claims
- Drugstores Denied Injunction In Calif. Medicaid Suit
- Novartis, Astellas, GSK Ads Misbranded Drugs: FDA
- Lundbeck Notches Win In Danish Cipralex Case
- Biovail Hits Paddock With 2nd Suit Over Aplenzin ANDA
- Davis Polk Reps Oracle In $685M Phase Forward Deal
- Fed. Circ. Rulings Offer Mixed Bag For Patent Owners
- No Stay For Apotex Amid Sanofi's Plavix Damages Push
- Fed. Circ. Rules Use Code Off Limits In Prandin IP Case
- Ranbaxy's US Branch Recalls Antibiotics Over Color
- Viagra Study Documents Can't Be Released: Judge
- Santarus' Patents For Heartburn Drug Invalid: Judge
- GSK Asks Again For Dismissal Of Wellbutrin IP Claims
- AstraZeneca Loses Bid To Nix Toprol Antitrust Suits
- Exclusive Gene Patents Can Hurt Competition: Study
- Pozen, Teva Bury Hatchet Over Treximet
- Stryker Surgical Implant Kickback Suit Loses Legs
- Case Over GE's Omniscan Survives Dismissal Bid
- Top Product Liability Rulings For 1st Quarter
- Bayer Updates Blood Clot Risk Info For Yasmin Label
- Endo, Penwest Reach Opana License Deal With Barr
- FDA Proposes Rules For Listing Side Effects In Ads
- Perrigo, Graceway Strike Deal Over Generic Aldara
- K-Dur Direct Purchasers Appeal Antitrust Suit Ruling
- Changes To Divisibility, Arranger Liability In CERCLA
- A Viable Theory Of Sham Infringement Litigation?
- Boston Sci Misled Investors After Guidant Deal: Suit
- $110M E-Ferol Settlement Gets Final Approval
- GSK, Glenmark Resolve Malaria Drug Patent Dustup
- Boston Sci Appeals Cordis Stent Patent Win
- Perrigo Triumphs In Trial Over Rexall's False Ad Claims
- Applied Medical Fights $4.8M Verdict In Surgery IP Suit
- Cohen Milstein OK'd As Counsel In Plasma Pricing MDL
- Warner Chilcott, Roche Sue Mylan Over Actonel ANDA
- Novartis Ignored Consultant's Sex Bias Findings: Atty
- Radiation Therapy Devices Face FDA Scrutiny
- Medtech, DenTek Resolve Mouth Guard Patent Battle
- IP Enforcement In China Still A Work In Progress
- Mayer Brown Sheds Nearly 30 Attys
- Smith & Nephew Seeks New Trial In Kinetic IP Suit
- Ex-'Biggest Loser' Says Diet Cos. Ripping Off Her Image
- FDA Warns Edwards Over Heart Device Reporting
- Fed. Circ. Upholds Icos' Ownership Of Cialis Patents
- Bioenvision Shareholder Suit Rightly Nixed: 2nd Circ.
- US Oftalmi Recalls Eye, Nose Drops Over Sterility
- Hemispherx's Hostile Takeover Suit Stays Alive
- FDA Cracks Down On Spas' Lipodissolve Claims
- PharMerica's Contract Interference Suit Survives
- 3rd Circ. Affirms Slimmer Case Against Ex-BMS Exec
- FDA Warns Gilead, Biogen Over Drug Ads
- J&J, Omnicare Hit With Class Action Over Kickbacks
- Novartis Sex Bias Class Action Goes To Trial In NY
- Aware Settles Acacia Unit's Medical Imaging IP Suit
- Health Care Reform Means New Disclosure Rules
- Last Defendants Settle With Sanofi Over Eloxatin
- Bristol-Myers, Takeda Hit With False Marking Suits
- AstraZeneca Win In Seroquel Bellwether Affirmed
- UGA To Pay Inventor $20M Over Restasis Patents
- Purdue Settles Ark. Fund's OxyContin Antitrust Suit
- Guidant Pleads Guilty In Defibrillator Safety Case
- Apotex Asks DC Circ. To Stay Teva's Hyzaar Exclusivity
- Sperm Bank Not Liable For 'Defective' Semen: 3rd Circ.
- Merck Sues Novartis Unit Over Cancidas ANDA
- Boehringer Ingelheim Hit With Don, Doff Suit
- Mexico To Usher In Harsher Penalties For Monopolies
- NeoPharm Investors' Class Action Trimmed
- Ballard Spahr Leads Medegen In $225M CareFusion Deal
- Medtronic To Appeal Edwards' $74M Heart Valve IP Win
- Dentsply Must Face Rivals' Federal Antitrust Claims
- Pa. Supreme Court Blocks Appeal In Prempro Case
- Fed. Circ. Further Untangles HIF Bio Inventorship Fight
- Teva's Gemzar ANDAs Infringe Lilly Patent: Judge
- Fed. Circ. Nixes Suit To Invalidate Kinetic Patents
- La. Allowed To Pursue Vioxx Refund From Merck
- Lilly, Sandoz Can't End Generic Prozac Suicide Case
- Sanofi Settles With Teva, Others Over Generic Eloxatin
- FDA Rolls Out Pediatric Info Rule For Device Makers
- Teva Gets Win In Birth Control IP Battle Against Watson
- Hospital, Health Plans End Oxycontin Antitrust Suits
- Novo Nordisk Patent Suit Over Prandin Nixed
- Teva Fights To Keep Exclusivity On Hypertension Drugs
- Lilly Settles La. AG Zyprexa Claims For $20M